InvestorsHub Logo
Followers 12
Posts 749
Boards Moderated 0
Alias Born 05/22/2007

Re: None

Wednesday, 01/11/2023 5:51:04 PM

Wednesday, January 11, 2023 5:51:04 PM

Post# of 427040
I remain disappointed in the apparent resignation of the US market. It is not clear the AMRN has had any low cost targeted push via social media go grow total V or share. It is not clear they have taken advantage of tv and radio medical shows to appear as quests. It is not clear that they have approached the states that require generic and remind them it is theft of IP in the case of V for CV. I wonder why they haven't communicated to all pharmacists reminding them that only V has FDA cred for CV applications and that other prescriptions are either ineffective (lovenza) or theft of IP. I wonder if a direct to consumer ad reminding that V is the only authorized EPA product for CV and that being party to taking or prescribing gv for that application is contributory to IP theft.

They should push until someone pushes back.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News